172 related articles for article (PubMed ID: 30658234)
1. O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors.
Karamitri A; Sadek MS; Journé AS; Gbahou F; Gerbier R; Osman MB; Habib SAM; Jockers R; Zlotos DP
Bioorg Chem; 2019 Apr; 85():349-356. PubMed ID: 30658234
[TBL] [Abstract][Full Text] [Related]
2. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT
Legros C; Dupré C; Brasseur C; Bonnaud A; Bruno O; Valour D; Shabajee P; Giganti A; Nosjean O; Kenakin TP; Boutin JA
Pharmacol Res Perspect; 2020 Feb; 8(1):e00539. PubMed ID: 31893123
[TBL] [Abstract][Full Text] [Related]
4. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
[TBL] [Abstract][Full Text] [Related]
5. Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers.
Kamal M; Gbahou F; Guillaume JL; Daulat AM; Benleulmi-Chaachoua A; Luka M; Chen P; Kalbasi Anaraki D; Baroncini M; Mannoury la Cour C; Millan MJ; Prevot V; Delagrange P; Jockers R
J Biol Chem; 2015 May; 290(18):11537-46. PubMed ID: 25770211
[TBL] [Abstract][Full Text] [Related]
6. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
7. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a highly selective and potent partial agonist of the MT₂ melatonin receptor.
Sakurai T; Koike T; Nakayama M
Pharmacology; 2014; 93(5-6):244-52. PubMed ID: 25059758
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Jeanty M; Suzenet F; Delagrange P; Nosjean O; Boutin JA; Caignard DH; Guillaumet G
Bioorg Med Chem Lett; 2011 Apr; 21(8):2316-9. PubMed ID: 21420861
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
11. 2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT
Mari M; Elisi GM; Bedini A; Lucarini S; Retini M; Lucini V; Scaglione F; Vincenzi F; Varani K; Castelli R; Mor M; Rivara S; Spadoni G
Eur J Med Chem; 2022 Dec; 243():114762. PubMed ID: 36150258
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
14. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
Ayoub MA; Levoye A; Delagrange P; Jockers R
Mol Pharmacol; 2004 Aug; 66(2):312-21. PubMed ID: 15266022
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligands.
Charton I; Suzenet F; Boutin JA; Audinot V; Delagrange P; Bennejean C; Renard P; Guillaumet G
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):187-93. PubMed ID: 12943203
[TBL] [Abstract][Full Text] [Related]
16. Melatonin MT
Chen M; Cecon E; Karamitri A; Gao W; Gerbier R; Ahmad R; Jockers R
J Pineal Res; 2020 May; 68(4):e12641. PubMed ID: 32080899
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
18. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
Stein RM; Kang HJ; McCorvy JD; Glatfelter GC; Jones AJ; Che T; Slocum S; Huang XP; Savych O; Moroz YS; Stauch B; Johansson LC; Cherezov V; Kenakin T; Irwin JJ; Shoichet BK; Roth BL; Dubocovich ML
Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
[TBL] [Abstract][Full Text] [Related]
19. Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
Bolteau R; Descamps F; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
Eur J Med Chem; 2020 Mar; 189():112078. PubMed ID: 32004937
[TBL] [Abstract][Full Text] [Related]
20. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
